AspireAssist Weight Loss Procedure

It is FDA-approved and does not require invasive surgery. The device is placed in the stomach in a short 15-minute procedure and prevents about 30% of calories from being absorbed when used properly. It is available in the United States, Europe, the Middle East, Australia, and New Zealand. In 2013, positive interim results were reported in Sweden, and in 2012, a US clinical trial began enrolling participants.